David R. Holland
Net Worth

Last updated:

What is David R. Holland net worth?

The estimated net worth of Mr. David R. Holland is at least $6,774,001 as of 3 Nov 2021. He has earned $333,601 from insider trading and has received compensation worth at least $6,440,400 in Alimera Sciences, Inc..

What is the salary of David R. Holland?

Mr. David R. Holland salary is $429,360 per year as Co-Founder, Chief Marketing Officer and Senior Vice President of Corporation Communications & Managed Markets in Alimera Sciences, Inc..

How old is David R. Holland?

Mr. David R. Holland is 61 years old, born in 1964.

What stocks does David R. Holland currently own?

As insider, Mr. David R. Holland owns shares in one company:

Company Title Shares Price per share Total value
Alimera Sciences, Inc. (ALIM) Co-Founder, Chief Marketing Officer and Senior Vice President of Corporation Communications & Managed Markets 31,130 $0 $0

What does Alimera Sciences, Inc. do?

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.

ALIM logo
ALIM
Alimera Sciences, Inc.

David R. Holland insider trading

Alimera Sciences, Inc.

Mr. David R. Holland has made 17 insider trades between 2010-2021, according to the Form 4 filled with the SEC. Most recently he purchased 5,000 units of ALIM stock worth $20,390 on 3 Nov 2021.

The largest trade he's ever made was exercising 30,000 units of ALIM stock on 17 May 2013. As of 3 Nov 2021 he still owns at least 31,130 units of ALIM stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 5,000 $4.08 $20,390
Sale
Common Stock 12,750 $1.18 $15,045
Sale
Common Stock 12,750 $1.18 $15,045
Sale
Common Stock 12,750 $1.23 $15,695
Sale
Common Stock 12,750 $1.23 $15,695
Option
Employee Stock Option (Right to Buy) 27,971 $1.33 $37,201
Option
Common Stock 27,971 $1.33 $37,201
Option
Common Stock 5,000 $1.33 $6,650
Sale
Common Stock 5,000 $1.33 $6,650
Option
Employee Stock Option (Right to Buy) 5,000 $1.33 $6,650
Option
Common Stock 5,000 $1.33 $6,650
Option
Employee Stock Option (Right to Buy) 5,000 $1.33 $6,650
Sale
Common Stock 5,000 $5.71 $28,550
Sale
Common Stock 5,000 $1.33 $6,650
Option
Employee Stock Option (Right to Buy) 5,000 $1.33 $6,650
Option
Common Stock 5,000 $1.33 $6,650
Option
Employee Stock Option (Right to Buy) 5,000 $1.33 $6,650
Option
Common Stock 5,000 $1.33 $6,650
Sale
Common Stock 5,000 $1.33 $6,650
Sale
Common Stock 5,000 $1.33 $6,650
Option
Common Stock 5,000 $1.33 $6,650
Option
Employee Stock Option (Right to Buy) 5,000 $1.33 $6,650
Option
Common Stock 5,000 $1.33 $6,650
Sale
Common Stock 5,000 $1.33 $6,650
Option
Employee Stock Option (Right to Buy) 5,000 $1.33 $6,650
Option
Employee Stock Option (Right to Buy) 5,000 $1.33 $6,650
Sale
Common Stock 5,000 $1.33 $6,650
Option
Common Stock 5,000 $1.33 $6,650
Sale
Common Stock 5,000 $5.73 $28,650
Option
Common Stock 5,000 $1.69 $8,425
Option
Employee Stock Option (Right to Buy) 5,000 $1.69 $8,425
Option
Employee Stock Option (Right to Buy) 5,000 $2.04 $10,200
Sale
Common Stock 5,000 $2.04 $10,200
Option
Common Stock 5,000 $2.04 $10,200
Option
Common Stock 10,000 $2.04 $20,400
Sale
Common Stock 10,000 $2.04 $20,400
Option
Employee Stock Option (Right to Buy) 10,000 $2.04 $20,400
Sale
Common Stock 5,000 $2.04 $10,200
Option
Employee Stock Option (Right to Buy) 5,000 $2.04 $10,200
Option
Common Stock 5,000 $2.04 $10,200
Option
Common Stock 5,000 $2.04 $10,200
Sale
Common Stock 5,000 $2.04 $10,200
Option
Employee Stock Option (Right to Buy) 5,000 $2.04 $10,200
Sale
Common Stock 30,000 $4.13 $124,020
Purchase
Common Stock 381 $9.14 $3,482

Alimera Sciences key executives

Alimera Sciences, Inc. executives and other stock owners filed with the SEC:

  • Dr. Philip Ashman (60) Chief Operating Officer & Senior Vice President of Commercial Operations - Europe
  • Mr. Charles Daniel Myers (71) Non-Executive Chairman & Consultant
  • Mr. David R. Holland (61) Co-Founder, Chief Marketing Officer and Senior Vice President of Corporation Communications & Managed Markets
  • Mr. Richard S. Eiswirth Jr. (57) Pres, Chief Executive Officer & Director